Back to search

France· FR:66769558

PHENYLEPHRINE RENAUDIN 50 microgrammes/ml, solution injectable

A medicinal product containing chlorhydrate de phényléphrine, registered in France by LABORATOIRE RENAUDIN.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPHENYLEPHRINE RENAUDIN 50 microgramme…ATC—REGISTER NO.FR:66769558PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE DE PHÉNYLÉPHRINE
Manufacturer
LABORATOIRE RENAUDIN
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400958056420
    10 ampoule(s) en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Chlorhydrate de phényléphrine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlorhydrate de phényléphrine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Biorphen, Phenylephrin Aguettant
  • Belgium · Minims Fenylefrinehydrochloride Bausch + Lomb Ireland Limited, Minims Phenylephrine Chlorhydrate Bausch + Lomb Ireland Limited
  • Bulgaria · Фенилефрин Вижън, Фенилефрин Вижън Антибиотик-Разград Ад
  • Cyprus · Biorphen
  • Czechia · Neosynephrin-Pos, Phenylephrine Olikla
  • Germany · Biorphen, Neosynephrin-Pos
  • Denmark · Biorphen, Fenylefrin Abcur
  • Estonia · Biorphen
  • Spain · Colircusí, Disneumon Pernasal
  • Finland · Fenylefrin Abcur, Fenylefrin Aguettant
  • United Kingdom (Northern Ireland) · Blocked Nose Relief, Flamingo Max Strength Congestion Relief
  • Greece · Biorphen, Phenylephrine Cooper
  • Croatia · Biorphen
  • Hungary · Biorphen
  • Ireland · Minims, Phenylephrine Hydrochloride Athlone Pharmaceuticals
  • Iceland · Biorphen, Fenylefrin Abcur
  • Italy · Fenilefrina Aguettant, Nasomixin C.M.
  • Luxembourg · Minims Phenylephrine Chlorhydrate Bausch + Lomb Ireland Limited, Minims Phenylephrinhydrochlorid Bausch + Lomb Ireland Limited
  • Latvia · Biorphen
  • Malta · Phenylephrine Laboratoire Aguettant
  • Netherlands · Fenylefrine Added Pharma, Fenylefrine Aguettant
  • Norway · Biorphen, Fenylefrin Abcur
  • Poland · Acatar Acti Form, Anosin
  • Portugal · Davinefrina, Fenilefrina Aguettant
  • Romania · Bioflu Nazal, Fenefrin
  • Sweden · Fenylefrin Abcur, Fenylefrin Aguettant
  • Slovenia · Fenilefrin Sintetica
  • Slovakia · Fenefrin, Phenylephrine Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/aa04dff5-69cb-462b-8034-fe56e9536a3c
GET /v1/drugs/aa04dff5-69cb-462b-8034-fe56e9536a3c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66769558",
  "date_amm": "2011-08-25",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "CHLORHYDRATE DE PHÉNYLÉPHRINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about chlorhydrate de phényléphrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.